Search research articles
Contact Us
Filters
Showing results (131-140 of 140) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 140 results.
Acta Neuropathologica Communications
|
August 9, 2020
Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity
Oeystein R Brekk, Joanna A Korecka, Cecile C Crapart, et al.
Antioxidants & Redox Signaling
|
June 23, 2015
Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice
Emily M Rocha, Gaynor A Smith, Eric Park, et al.
Cell Stem Cell
|
March 4, 2015
Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease
Penelope J Hallett, Michela Deleidi, Arnar Astradsson, et al.
Experimental Neurology
|
June 8, 2014
ALS-associated peripherin spliced transcripts form distinct protein inclusions that are neuroprotective against oxidative stress
Jesse R McLean, Gaynor A Smith, Emily M Rocha, et al.
Molecular Neurobiology
|
March 30, 2016
Genetic Variants of Microtubule Actin Cross-linking Factor 1 (MACF1) Confer Risk for Parkinson's Disease
Xin Wang, Nuomin Li, Nian Xiong, et al.
Stem Cell Reports
|
January 1, 2019
Neurite Collapse and Altered ER Ca<sup>2+</sup> Control in Human Parkinson Disease Patient iPSC-Derived Neurons with LRRK2 G2019S Mutation
Joanna A Korecka, Sebastien Talbot, Teresia M Osborn, et al.
Neurobiology of Disease
|
October 24, 2013
LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: reversal by gene correction
Laurie H Sanders, Josée Laganière, Oliver Cooper, et al.
Science Translational Medicine
|
July 6, 2012
Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease
Oliver Cooper, Hyemyung Seo, Shaida Andrabi, et al.
Biorxiv : the Preprint Server for Biology
|
May 22, 2023
Crucial neuroprotective roles of the metabolite BH4 in dopaminergic neurons
Shane J F Cronin, Weonjin Yu, Ashley Hale, et al.
Plos One
|
September 7, 2012
Creation of an open-access, mutation-defined fibroblast resource for neurological disease research
Selina Wray, Matthew Self, , et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 140) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 140 results.
Acta Neuropathologica Communications
|
August 9, 2020
Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity
Oeystein R Brekk, Joanna A Korecka, Cecile C Crapart, et al.
Antioxidants & Redox Signaling
|
June 23, 2015
Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice
Emily M Rocha, Gaynor A Smith, Eric Park, et al.
Cell Stem Cell
|
March 4, 2015
Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease
Penelope J Hallett, Michela Deleidi, Arnar Astradsson, et al.
Experimental Neurology
|
June 8, 2014
ALS-associated peripherin spliced transcripts form distinct protein inclusions that are neuroprotective against oxidative stress
Jesse R McLean, Gaynor A Smith, Emily M Rocha, et al.
Molecular Neurobiology
|
March 30, 2016
Genetic Variants of Microtubule Actin Cross-linking Factor 1 (MACF1) Confer Risk for Parkinson's Disease
Xin Wang, Nuomin Li, Nian Xiong, et al.
Stem Cell Reports
|
January 1, 2019
Neurite Collapse and Altered ER Ca<sup>2+</sup> Control in Human Parkinson Disease Patient iPSC-Derived Neurons with LRRK2 G2019S Mutation
Joanna A Korecka, Sebastien Talbot, Teresia M Osborn, et al.
Neurobiology of Disease
|
October 24, 2013
LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: reversal by gene correction
Laurie H Sanders, Josée Laganière, Oliver Cooper, et al.
Science Translational Medicine
|
July 6, 2012
Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease
Oliver Cooper, Hyemyung Seo, Shaida Andrabi, et al.
Biorxiv : the Preprint Server for Biology
|
May 22, 2023
Crucial neuroprotective roles of the metabolite BH4 in dopaminergic neurons
Shane J F Cronin, Weonjin Yu, Ashley Hale, et al.
Plos One
|
September 7, 2012
Creation of an open-access, mutation-defined fibroblast resource for neurological disease research
Selina Wray, Matthew Self, , et al.
Page
of 14